Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerNeoplasia: the second decade.Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.A comprehensive map of the human urinary proteomeInterleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.The present and future of prostate cancer urine biomarkers.GP73 is down-regulated in gastric cancer and associated with tumor differentiation.Hepatocyte GP73 expression in Wilson disease.Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma.Prostate cancer: the need for biomarkers and new therapeutic targets.The War on Cancer rages on.Urine markers in monitoring for prostate cancer.Urine biomarkers in prostate cancer.Diagnostic and prognostic molecular biomarkers for prostate cancer.Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective.Biomarkers for the diagnosis of new and recurrent prostate cancer.Urine markers and prostate cancerEarly dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer.Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance.Use of two gene panels for prostate cancer diagnosis and patient risk stratification.Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA.Discovery of Gene Regulation Pattern in Lung Cancer by Gene Expression Profiling Using Human Tissues.Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A.GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.Golgi protein 73 as a biomarker of hepatocellular cancer: development of a quantitative serum assay and expression studies in hepatic and extrahepatic malignancies.Quadriplex model enhances urine-based detection of prostate cancer.Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.Overexpression of golgi membrane protein 1 promotes non-small-cell carcinoma aggressiveness by regulating the matrix metallopeptidase 13.
P2860
Q24628746-2EEFCA95-B98E-4FE8-8D50-FBBECFEEE487Q30484000-79BDAB0C-581D-474D-B49D-FCADE8CF63F2Q33697764-CCF58D68-83FB-433C-91D6-1C68FAF1377EQ34424829-C13242A0-3E0B-417A-80AA-31B6993EC1FEQ36393694-73BD96CF-49D4-4D34-A0E8-50B7EC991593Q37007392-5B85EA6C-B0EE-487E-999C-BF900110C0F0Q37014166-EE33E5FB-BBC5-4FE4-B03F-93F63233FFB9Q37361200-E1A4A6D3-F3B3-4FF1-BAE1-EBF68AC1D3ABQ37420203-90BDB4C1-3547-4B67-AA1F-D620BF120919Q37476043-AFED2212-38C2-484E-9C70-20AAE4DC0181Q37478602-86D72FB2-202F-4852-9E4D-656B8F98DD75Q37571461-26DA7FEF-937B-4234-8891-AD5A31895078Q37672247-5CF3D1DB-6AC2-4D00-8C24-491D107B37F3Q37972703-86C93A37-C38C-4242-8C61-AC8751FA1742Q38034447-2025508F-E2DF-4B2E-8C18-D5D613CBAB4FQ38052926-5F9AB295-F76C-4DB2-91FB-3F4DCA5A2D05Q38191924-838DFF37-EB9D-4C4B-A5B6-3746FEB0FF4BQ38489314-45838D6D-EB4E-41E2-91E3-D01434BD394FQ38613772-70EF6AE4-9A8D-4940-BF34-A12A6478C21AQ39053139-D8530B5C-AEA3-4663-844F-AB48D0BD47ECQ40553485-D5A7A093-FF7A-4E00-9F32-8C414F6EE363Q40945727-0675AD53-2CB2-4C52-80D5-6F63EF3D1AD9Q41147066-F926AF60-131D-4DC9-9218-BCF253F24A49Q41461038-9F1AF3A7-6CAF-4063-8909-C74A69675CBEQ41564129-23B9CEEE-2099-454A-89F9-FE725F1F8A4FQ42184292-5B64C191-14E1-4D8E-8A4E-53F64D50C1FCQ47271028-23BF93F3-17E5-4162-B59F-D9A6CE0DC58AQ47357247-62EF0D57-2D7B-449F-9C94-4E2C7ACFE871Q47919341-0010A312-7A98-403C-9483-82E24269A91BQ50618165-BE4CA7C3-2D8F-431D-8BE1-FAF0084E52C2Q51765488-1B29623C-FF65-49F7-A5C2-48586F13900CQ55176397-96E3E73F-9C5E-49C0-ACBD-57DF688B21CE
P2860
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@ast
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@en
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@nl
type
label
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@ast
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@en
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@nl
prefLabel
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@ast
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@en
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer
@en
P2093
Adaikkalam Vellaichamy
Arul M Chinnaiyan
Arun Sreekumar
Bharathi Laxman
Claus J Fimmel
Jianjun Yu
Jill Granger
Lorinda M Wright
Rainer Kuefer
Raleigh D Kladney
P2860
P304
P3181
P356
10.1593/NEO.08922
P407
P577
2008-11-01T00:00:00Z